Detailed price information for Structure Therapeutics Inc (GPCR-Q) from The Globe and Mail including charting and trades.

As anticipation builds around the Union Budget 2025, investors, businesses, and policymakers eagerly await key reforms that ...

Novartis AG (NYSE:NVS), a global healthcare company valued at over $206 billion, has undergone significant transformation in recent years, focusing its efforts on becoming a pure-play pharmaceutical ...

Industry stalwarts discuss pharma industry's resilience, future opportunities and expectations from Union Budget 2025: Shardul Nautiyal, Mumbai Thursday, January 30, 2025, 14:30 H ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

Obesity significantly impacts cardiovascular health, increasing risks such as left ventricular hypertrophy, atherosclerosis, ...

FOPE expects rationalization of GST rates for pharma in Union Budget 2025: Nandita Vijayasimha, Bengaluru Tuesday, January 28, 2025, 08:00 Hrs [IST] The Federation of Pharma Entre ...

Still, there have been impacts on companies that particularly service the pharmaceutical industry, such as contract research ...

The pharmaceutical industry is experiencing an exciting transformation, shifting from transactional partnerships to strategic ...

Teva Pharmaceutical Indus's TEVA short percent of float has risen 16.99% since its last report. The company recently reported ...

Saransh Chaudhary, President, Global Critical Care, Venus Remedies Ltd and CEO, Venus Medicine Research Centre said that they ...